LXEO
Price
$7.39
Change
-$0.11 (-1.47%)
Updated
Jan 16 closing price
Capitalization
539.38M
58 days until earnings call
Intraday BUY SELL Signals
QURE
Price
$22.84
Change
+$0.86 (+3.91%)
Updated
Jan 16 closing price
Capitalization
1.42B
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LXEO vs QURE

Header iconLXEO vs QURE Comparison
Open Charts LXEO vs QUREBanner chart's image
Lexeo Therapeutics
Price$7.39
Change-$0.11 (-1.47%)
Volume$1.03M
Capitalization539.38M
uniQure
Price$22.84
Change+$0.86 (+3.91%)
Volume$1.57M
Capitalization1.42B
LXEO vs QURE Comparison Chart in %
LXEO
Daily Signal:
Gain/Loss:
QURE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LXEO vs. QURE commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXEO is a Hold and QURE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (LXEO: $7.39 vs. QURE: $22.84)
Brand notoriety: LXEO and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXEO: 75% vs. QURE: 64%
Market capitalization -- LXEO: $539.38M vs. QURE: $1.42B
LXEO [@Biotechnology] is valued at $539.38M. QURE’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXEO’s FA Score shows that 0 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • LXEO’s FA Score: 0 green, 5 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, QURE is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXEO’s TA Score shows that 4 TA indicator(s) are bullish while QURE’s TA Score has 4 bullish TA indicator(s).

  • LXEO’s TA Score: 4 bullish, 5 bearish.
  • QURE’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, QURE is a better buy in the short-term than LXEO.

Price Growth

LXEO (@Biotechnology) experienced а -29.89% price change this week, while QURE (@Biotechnology) price change was -9.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

LXEO is expected to report earnings on Mar 16, 2026.

QURE is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($1.42B) has a higher market cap than LXEO($539M). QURE YTD gains are higher at: -4.555 vs. LXEO (-25.579). LXEO has higher annual earnings (EBITDA): -102.69M vs. QURE (-146.3M). QURE has more cash in the bank: 694M vs. LXEO (123M). LXEO has less debt than QURE: LXEO (8.46M) vs QURE (66.2M). QURE has higher revenues than LXEO: QURE (15.8M) vs LXEO (0).
LXEOQURELXEO / QURE
Capitalization539M1.42B38%
EBITDA-102.69M-146.3M70%
Gain YTD-25.579-4.555562%
P/E RatioN/AN/A-
Revenue015.8M-
Total Cash123M694M18%
Total Debt8.46M66.2M13%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LXEOQURE
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
LXEO
Daily Signal:
Gain/Loss:
QURE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RISSX13.060.05
+0.38%
RBC International Small Cap Equity A
CMLIX49.560.08
+0.16%
Congress Large Cap Growth Institutional
FHEAX15.25N/A
N/A
Fidelity Advisor Real Estate A
AMVGX15.43-0.01
-0.06%
American Century Mid Cap Value R5
VAGVX31.66-0.06
-0.19%
Vanguard Advice Select Global Value Adml

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with QURE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
-1.47%
QURE - LXEO
42%
Loosely correlated
+3.91%
CLDX - LXEO
42%
Loosely correlated
-0.16%
CGON - LXEO
41%
Loosely correlated
+3.13%
TSHA - LXEO
40%
Loosely correlated
-6.94%
DYN - LXEO
40%
Loosely correlated
+1.74%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NEVPF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
+3.91%
NEVPF - QURE
50%
Loosely correlated
N/A
LXEO - QURE
42%
Loosely correlated
-1.47%
AXON - QURE
42%
Loosely correlated
-0.18%
BCYC - QURE
38%
Loosely correlated
+0.62%
MLTX - QURE
37%
Loosely correlated
+2.51%
More